Tag - PRFMF

Developments

Profound Medical sees five-fold jump in preliminary Q4 revenue versus Q3

Profound Medical (TSX:PRN; OTCQX:PRFMF) expects total revenue of about $1.6-million for the fourth quarter of 2018, up from about $300,000 for the third quarter last year. For all of 2018, the company expects total...

January 4, 2019

Executive Moves

Profound Medical appoints Ian Heynen as SVP sales and marketing

Profound Medical (TSXV:PRN; OTCQX:PRFMF) appointed Ian Heynen as SVP of sales and marketing. Mr. Heynen brings to Profound more than 15 years of progressive leadership experience, working with medical device companies...

April 23, 2018

Feature

Profound makes leap to platform company from prostate product

By Len Zehr Arun Menawat, CEO With its recent acquisition of Royal Philips’ (NYSE:PHG; AEX:PHIA) Sonalleve business, Profound Medical (OTCQX:PRFMF; TSXV:PRN) is making the leap from a medical device company focused on...

September 5, 2017

Feature

Profound Medical’s TULSA-PRO pilot OUS launch: paving the way for global growth

By Len Zehr After nearly a decade of R&D, Profound Medical (OTCQX:PRFMF; TSXV:PRN) is now conducting a pilot launch of its TULSA-PRO medical device to ablate tissue in localized prostate cancer within key European...

March 28, 2017

Tag - PRFMF

Profound Medical sees five-fold jump in preliminary Q4 revenue versus Q3

Profound Medical appoints Ian Heynen as SVP sales and marketing

Profound makes leap to platform company from prostate product

Profound Medical’s TULSA-PRO pilot OUS launch: paving the way for global growth

General

More